stars 1 stars 2 stars 3

ArisGen is a research-based team dedicated to innovation in the field of drug delivery as a way to improve health. Its professionals have many years of combined experience in drug delivery, know the limitations of presently available tools, and have developed a new platform to help overcome them. ArisGen has developed novel, fully independent IP to provide effective solutions to deliver drugs, from mode of administration to target. ArisGen technology (ArisCrown) open new avenues for: • Oral (sublingual or gastrointestinal) delivery of biologic drugs • Managed release and enhanced bioavailability Arisgen is located in Plan-Les-Ouates near Geneva, Switzerland. The Company was founded in 2006 by Dr. Paolo Botti, CEO & CSO and the inventor of its ariscrown and aristarget technologies.

Arisgen SA Questions

The Arisgen SA annual revenue was $800000 in 2026.

Arisgen SA is based in Plan les ouates, Geneva.

The NAICS codes for Arisgen SA are [54, 3254, 32, 325, 541].

The SIC codes for Arisgen SA are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users